Home › Funds › Sands Capital Alternatives, LLC › ODTX
Sands Capital Alternatives, LLC position in ODTX
Odyssey Therapeutics Inc · Health Care
Sands Capital Alternatives, LLC reported holding 875,000 shares of ODTX (Odyssey Therapeutics Inc) in its Q3 2026 13F filing — a position valued at US$19.4M, representing 2.88% of its reported portfolio and ranking #10 among its reported holdings. Sands Capital Alternatives, LLC has disclosed ODTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Sands Capital Alternatives, LLC's ODTX position evolved
Sands Capital Alternatives, LLC first disclosed a stake in ODTX in Q2 2026 at 875,000 shares (US$16.4M). The position peaked in Q3 2026 at 875,000 shares, worth US$19.4M. Across 2 filings, Sands Capital Alternatives, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 875,000 shares valued at US$19.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 875.00K | $16.37M | New |
| Q3 2026 | 875.00K | $19.44M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ODTX and 13F data
ODTX (Odyssey Therapeutics Inc) is a Health Care company. 76 other funds we track also report a position in ODTX — the largest reported positions include SR ONE CAPITAL MANAGEMENT, LP (US$71.0M), TPG GP A, LLC (US$69.0M), Lightspeed Management Company, L.L.C. (US$67.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ODTX
- SR ONE CAPITAL MANAGEMENT, LP 3.79M sh · $71.00M · Q2 2026
- TPG GP A, LLC 3.69M sh · $69.04M · Q2 2026
- Lightspeed Management Company, L.L.C. 3.61M sh · $67.51M · Q2 2026
- ORBIMED ADVISORS LLC 3.00M sh · $56.15M · Q2 2026
- Sanofi 1.99M sh · $44.22M · Q3 2026
- Hillhouse Capital (HHLR Advisors) 831.66K sh · $15.56M · Q2 2026
- General Catalyst Group Management, LLC 810.27K sh · $15.16M · Q2 2026
- Affinity Asset Advisors, LLC 766.35K sh · $14.34M · Q2 2026
- Foresite Capital Management V, LLC 713.11K sh · $13.34M · Q2 2026
- Vivo Capital, LLC 575.00K sh · $12.78M · Q3 2026
- EcoR1 Capital, LLC 555.55K sh · $10.39M · Q2 2026
- Logos Global Management LP 521.74K sh · $9.76M · Q2 2026
More on Sands Capital Alternatives, LLC
FAQ
How long has Sands Capital Alternatives, LLC held ODTX?
Sands Capital Alternatives, LLC has disclosed ODTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Sands Capital Alternatives, LLC's current position in ODTX?
As of Q3 2026, Sands Capital Alternatives, LLC holds 875.00K shares of ODTX (Odyssey Therapeutics Inc), valued at $19.44M, representing 2.88% of its reported portfolio and ranking #10.
Has Sands Capital Alternatives, LLC been buying or selling ODTX?
In the latest 13F filing (Q3 2026), Sands Capital Alternatives, LLC held unchanged its position in ODTX. The position peaked in Q3 2026 at 875.00K shares.
Which other funds hold ODTX?
Other major institutional holders of ODTX include SR ONE CAPITAL MANAGEMENT, LP, TPG GP A, LLC, Lightspeed Management Company, L.L.C., among 76 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.